{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360862720288239488.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.15420/cfr.2023.05"}},{"identifier":{"@type":"URI","@value":"https://www.cfrjournal.com/articleindex/cfr.2023.05"}}],"dc:title":[{"@value":"Global Public Health Burden of Heart Failure: An Updated Review"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64 million people globally. Although the incidence of HF has stabilised worldwide and seems to be declining in developed countries, the prevalence is increasing due to the ageing of the population, improved survival after MI and improved treatment and survival of patients with HF. Yet, HF remains associated with high mortality and morbidity, poor quality of life and functional capacity, and confers a substantial burden to the healthcare system. The prevalence, incidence, mortality and morbidity rates reported show geographical variations, depending on the different aetiologies and clinical characteristics observed among patients with HF. In this review, we provide an overview of the global epidemiology of HF with updated data on prevalence, incidence, mortality and morbidity worldwide.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380862720288239489","@type":"Researcher","foaf:name":[{"@value":"Bahira Shahim"}],"jpcoar:affiliationName":[{"@value":"Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden"}]},{"@id":"https://cir.nii.ac.jp/crid/1380862720288239491","@type":"Researcher","foaf:name":[{"@value":"Chris J Kapelios"}],"jpcoar:affiliationName":[{"@value":"Department of Cardiovascular Medicine, University of Utah Health Sciences Center, Salt Lake City, UT, US"}]},{"@id":"https://cir.nii.ac.jp/crid/1380862720288239490","@type":"Researcher","foaf:name":[{"@value":"Gianluigi Savarese"}],"jpcoar:affiliationName":[{"@value":"Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden"}]},{"@id":"https://cir.nii.ac.jp/crid/1380862720288239488","@type":"Researcher","foaf:name":[{"@value":"Lars H Lund"}],"jpcoar:affiliationName":[{"@value":"Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"20577559"},{"@type":"PISSN","@value":"20577540"}],"prism:publicationName":[{"@value":"Cardiac Failure Review"}],"dc:publisher":[{"@value":"Radcliffe Medical Media Ltd"}],"prism:publicationDate":"2023-07-27","prism:volume":"9","prism:startingPage":"e11"},"reviewed":"false","dc:rights":["https://creativecommons.org/licenses/by-nc/4.0/legalcode"],"url":[{"@id":"https://www.cfrjournal.com/articleindex/cfr.2023.05"}],"createdAt":"2023-07-27","modifiedAt":"2023-07-27","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050303932805700864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Retention of locally injected human iPS cell-derived cardiomyocytes into the myocardium using hydrolyzed gelatin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869854345334528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Web-Based Education Program About Primary Palliative Care for Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390025352086224512","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of Enhanced Nutritional Care in Heart Failure　― A Systematic Review and Meta-Analysis ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1390581401102827264","@type":"Article","resourceType":"エディトリアル(editorial)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Role of B-Type Natriuretic Peptide in the Early Detection of Preclinical Heart Failure　― Is B-Type Natriuretic Peptide the Best Tool to Find the “Invisible Enemy”? ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1390867421576449408","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Reducing the Burden of Heart Failure in Japan With Dapagliflozin　― A Cost Offset Model (IMPLICATION HF) ―"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.15420/cfr.2023.05"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-24-0187_references_DOI_Sk8OyN1OPXdLn7NRj83yd00qgdp"},{"@type":"CROSSREF","@value":"10.1038/s41598-025-87885-w_references_DOI_Sk8OyN1OPXdLn7NRj83yd00qgdp"},{"@type":"CROSSREF","@value":"10.1253/circrep.cr-25-0022_references_DOI_Sk8OyN1OPXdLn7NRj83yd00qgdp"},{"@type":"CROSSREF","@value":"10.1253/circrep.cr-25-0117_references_DOI_Sk8OyN1OPXdLn7NRj83yd00qgdp"},{"@type":"CROSSREF","@value":"10.1097/jcn.0000000000001120_references_DOI_Sk8OyN1OPXdLn7NRj83yd00qgdp"}]}